Therapy reports
-
Oncology Collaboration and Licensing Deals 2021-2026October 2026$4,995.002,955 oncology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Psychiatry Collaboration and Licensing Deals 2019-2026October 2026$3,995.00612 psychiatry partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Infectious Disease Collaboration and Licensing Deals 2020-2026October 2026$4,995.001,762 infectious diseases partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2026October 2026$3,995.00Cardiovascular partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication analysis | Contract intelligence | Comprehensive deal directory
Learn More -
Hematology Collaboration and Licensing Deals 2016-2026October 2026$3,995.00234 hematology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Immunology Collaboration and Licensing Deals 2018-2026October 2026$3,995.00919 immunology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2026October 2026$3,995.00319 genitourinary partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Gastrointestinal Collaboration and Licensing Deals 2016-2026October 2026$3,995.00438 gastrointestinal partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication analysis | Contract intelligence
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2026October 2026$3,995.00649 metabolic partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2020-2026October 2026$3,995.00966 CNS partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication analysis | Contract intelligence | Comprehensive deal directory
Learn More
